Munafa Stock Market Course + Intraday & FNO calls 
Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)
Technical Analysis Report for NASDAQ stock ALNY Alnylam Pharmaceuticals. Dated: 22 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Opened at 299.12 and Closed at: 297.45, which is -1.03% of previous session's close. It moved within a range of 294.99 and 303.33
The session was a Bearish session with an average volume of 681300, which is 4.56% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 292.05 and resistance for tomorrow is 300.39
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 293.85, 290.25 resistance for tomorrow's hourly charts is 302.19, 306.93
10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 292.58 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 296.53 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 310.08 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 328.47 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Alnylam Pharmaceuticals is 387.83 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Alnylam Pharmaceuticals is at 296.53 and 200 DMA is at 387.83, while 50 DMA and 100 DMA are at 310.08 and 328.47 respectively
Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 296.53 and 20 EMA is at 298.31
| Date | Closing Price | 20 SMA | 20 EMA |
| 22 Fri May | 297.45 | 296.53 | 298.31 |
| 21 Thu May | 300.51 | 297.09 | 298.4 |
| 20 Wed May | 298.48 | 297.34 | 298.18 |
| 19 Tue May | 294.30 | 298.1 | 298.15 |
| 18 Mon May | 286.27 | 298.92 | 298.55 |
| 15 Fri May | 286.98 | 300.03 | 299.84 |
Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 310.08 and 50 EMA is at 310.01
| Date | Closing Price | 50 SMA | 50 EMA |
| 22 Fri May | 297.45 | 310.08 | 310.01 |
| 21 Thu May | 300.51 | 310.48 | 310.52 |
| 20 Wed May | 298.48 | 310.88 | 310.93 |
| 19 Tue May | 294.30 | 311.35 | 311.44 |
| 18 Mon May | 286.27 | 311.94 | 312.14 |
| 15 Fri May | 286.98 | 312.63 | 313.2 |
Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 328.47 and 100 EMA is at 330.2
| Date | Closing Price | 100 SMA | 100 EMA |
| 22 Fri May | 297.45 | 328.47 | 330.2 |
| 21 Thu May | 300.51 | 329.47 | 330.86 |
| 20 Wed May | 298.48 | 330.45 | 331.47 |
| 19 Tue May | 294.30 | 331.47 | 332.14 |
| 18 Mon May | 286.27 | 332.54 | 332.9 |
| 15 Fri May | 286.98 | 333.66 | 333.84 |
Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 387.83 and 200 EMA is at 343.69
| Date | Closing Price | 200 SMA | 200 EMA |
| 22 Fri May | 297.45 | 387.83 | 343.69 |
| 21 Thu May | 300.51 | 388.54 | 344.16 |
| 20 Wed May | 298.48 | 389.21 | 344.6 |
| 19 Tue May | 294.30 | 389.86 | 345.07 |
| 18 Mon May | 286.27 | 390.48 | 345.58 |
| 15 Fri May | 286.98 | 391.06 | 346.18 |
Urogen Pharma has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Urogen Pharma, about 21.32% more returns!
Alnylam Pharmaceuticals has performed better than Trupanion Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Tandem Diabetes in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Scholar Rock has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Scholar Rock, about 4.54% more returns!
Rhythm Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 5.89% more returns!
Alnylam Pharmaceuticals has performed better than Regeneron Pharmaceuticals in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Pulse Biosciences has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Pulse Biosciences, about 20.14% more returns!
Alkermes Plc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Alkermes Plc, about 9.33% more returns!
Amarin Corporation has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Amarin Corporation, about 4.91% more returns!
Arrowhead Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 8.41% more returns!
Biogen Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Biogen Inc, about 7.2% more returns!
Alnylam Pharmaceuticals has performed better than Catalyst Biosciences in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Celldex Therapeutics in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Collegium Pharmaceutical has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Collegium Pharmaceutical, about 5.29% more returns!
Alnylam Pharmaceuticals has performed better than Dbv Technologies in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Fortress Biotech has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Fortress Biotech, about 17.27% more returns!
Fennec Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 49.75% more returns!
Alnylam Pharmaceuticals has performed better than Harrow Health in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Innoviva Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals Technical analysis of indicators
Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Alnylam Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Alnylam Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Alnylam Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 291.66 and Alnylam Pharmaceuticals ALNY stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.
Alnylam Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALNY Experts View which covers a lot of information including buying and selling signals
ALNY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
